InsiderClue
← All stocks

Nurix Therapeutics, Inc.

NRIX Mostly scheduled
CIK 0001549595 #1793 in the set updated 17 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$13.90M
$2.89M on a plan · $10.80M straight out of an exercise
Sold at will
$210.74K
22 of 191 sales
Net
−$13.90M
−$210.74K against sales at will

By person

12 insiders · 196 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Ring Christine
Chief Legal Officer
—
$5.97M (78) scheduled
−$5.97M
9,110
0.0088%
$242.67K
+125.0%
van Houte Hans
Chief Financial Officer
—
$4.62M (45) scheduled
−$4.62M
40,166
0.0387%
$1.07M
—
Beaurang Pierre
Chief Business Officer
—
$1.84M (21) scheduled
−$1.84M
120,996
0.1166%
$3.22M
+3.7%
Hansen Gwenn
Chief Scientific Officer
—
$1.45M (42) scheduled
−$1.45M
117,227
0.1130%
$3.12M
+2,451%
Wolff Stefani
EVP and COO
—
$22.34K (5)
−$22.34K
6,113
0.0059%
$162.84K
+96.9%
Third Rock Ventures III, L.P. entity
10% owner
—
—
—
3,509,348
3.38%
$93.48M
+3,943%
COLUMN GROUP L P entity
10% owner
—
—
—
2,080,607
2.00%
$55.42M
—
Redmile Group, LLC entity
10% owner
—
—
—
1,176,470
1.13%
$31.34M
—
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% owner
—
—
—
784,313
0.7557%
$20.89M
—
Tjian Robert
Director
—
—
—
124,999
0.1204%
$3.33M
+275.0%
GREGORY JULIA P
Director
—
—
—
10,750
0.0104%
$286.35K
—
Kunkel Lori Anne
Director
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

22
Insider
Date
Role
Action
Shares
Price
Amount
Hansen Gwenn
31 Oct 2023
Chief Scientific Officer
Sell
1,633
$5.20
$8.49K
Ring Christine
31 Oct 2023
Chief Legal Officer
Sell
1,232
$5.20
$6.40K
van Houte Hans
31 Oct 2023
Chief Financial Officer
Sell
1,080
$5.20
$5.61K
Hansen Gwenn
31 Jul 2023
Chief Scientific Officer
Sell
1,884
$9.65
$18.19K
Ring Christine
31 Jul 2023
General Counsel
Sell
1,420
$9.65
$13.71K
van Houte Hans
31 Jul 2023
Chief Financial Officer
Sell
1,245
$9.65
$12.02K
Hansen Gwenn
1 May 2023
Chief Scientific Officer
Sell
1,136
$9.88
$11.22K
Ring Christine
1 May 2023
General Counsel
Sell
682
$9.88
$6.74K
van Houte Hans
1 May 2023
Chief Financial Officer
Sell
721
$9.88
$7.12K
Wolff Stefani
1 May 2023
EVP and COO
Sell
342
$9.88
$3.38K
Wolff Stefani
31 Oct 2022
EVP and COO
Sell
350
$12.88
$4.51K
Hansen Gwenn
31 Oct 2022
Chief Scientific Officer
Sell
1,165
$12.88
$15.01K
Ring Christine
31 Oct 2022
General Counsel
Sell
699
$12.88
$9.00K
van Houte Hans
31 Oct 2022
Chief Financial Officer
Sell
739
$12.88
$9.52K
Hansen Gwenn
1 Aug 2022
Chief Scientific Officer
Sell
1,186
$15.67
$18.58K
van Houte Hans
1 Aug 2022
Chief Financial Officer
Sell
752
$15.67
$11.78K
Wolff Stefani
1 Aug 2022
EVP and COO
Sell
356
$15.67
$5.58K
Ring Christine
1 Aug 2022
General Counsel
Sell
712
$15.67
$11.16K
Ring Christine
2 May 2022
General Counsel
Sell
660
$11.75
$7.76K
van Houte Hans
2 May 2022
Chief Financial Officer
Sell
697
$11.75
$8.19K
Wolff Stefani
2 May 2022
EVP and COO
Sell
330
$11.75
$3.88K
Hansen Gwenn
2 May 2022
Chief Scientific Officer
Sell
1,098
$11.75
$12.90K
Show all 196 transactions →

What was left out

Form 4 filings counted 242
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 143
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 32,280,499
Sales filed before the plan box existed 12
History held since 29 Jul 2020